Nomura Asset Management CO LTD Repligen Corp Transaction History

Nomura Asset Management CO LTD

  • $32.3 Billion
  • Q4 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023
BUY
$138.78 - $176.51 $154,045 - $195,926
1,110 Added 9.3%
13,050 $2.08 Million
Q4 2022

Jan 10, 2025
BUY
$162.42 - $220.56 $1.94 Million - $2.63 Million
11,940 New
11,940 $2.02 Million
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $1.94 Million - $2.63 Million
11,940 New
11,940 $2.02 Million
Q3 2022

Jan 10, 2025
BUY
$160.42 - $256.21 $0 - $0
0 New
0 $0
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$160.42 - $256.21 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$160.42 - $256.21 $0 - $0
0 New
0 $0
Q2 2022

Jan 10, 2025
BUY
$140.68 - $188.02 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022
BUY
$140.68 - $188.02 $0 - $0
0 New
0 $0
Q1 2022

Jan 10, 2025
BUY
$161.19 - $257.96 $0 - $0
0 New
0 $0
Q1 2022

May 13, 2022
BUY
$161.19 - $257.96 $0 - $0
0 New
0 $0
Q4 2021

Jan 10, 2025
BUY
$247.59 - $304.47 $0 - $0
0 New
0 $0
Q4 2021

Feb 01, 2022
BUY
$247.59 - $304.47 $0 - $0
0 New
0 $0
Q3 2021

Jan 10, 2025
BUY
$194.77 - $324.21 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021
BUY
$194.77 - $324.21 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021
SELL
$165.87 - $220.95 $0 - $0
0 Closed
0 $0
Q1 2021

Jan 10, 2025
BUY
$180.37 - $226.26 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021
BUY
$180.37 - $226.26 $0 - $0
0 New
0 $0
Q4 2020

Jan 10, 2025
BUY
$148.08 - $206.57 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021
BUY
$148.08 - $206.57 $0 - $0
0 New
0 $0

Others Institutions Holding RGEN

# of Institutions
476
Shares Held
55.6M
Call Options Held
311K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.09B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email